BioNTech Acquires Struggling Neon for US$67 M
By Michelle Liu
Pharma Deals Review: Vol 2020 Issue 1 (Table of Contents)
Published: 24 Jan-2020
DOI: 10.3833/pdr.v2020.i1.2502 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a bid to enhance its global position in T-cell therapies, BioNTech has agreed to pay US$67 M for Neon Therapeutics, which is developing novel neoantigen-based T-cell therapies...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS